Robert J. Walden

Chief Financial Officer

Robert J. Walden has more than 25 years executive level experience in Maryland-based, life science companies performing basic and pre-clinical research, clinical development, manufacturing and international sales. Mr. Walden has held the position of Chief Financial Officer with the American Type Culture Collection and Osiris Therapeutics, Inc., Chief Financial Officer and Division President of Large Scale Biology Corporation, and Executive Director at GenVec, Inc. and concurrently serves as the Managing Partner of EDGE BioRealty. Mr. Walden received his B.S. in Finance from the University of Maryland.

« Back to Prolias Management